Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

How Trichomonas steals resources and evades your immune system

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Having had trichomoniasis protects you from almost nothing. About 1 in 5 people are infected again within three months of being treated, and while most of that is reinfection from untreated partners, part of it is that the immune system never builds a proper defence.

Here is what the parasite does to make sure of that.

Related pages: Trichomoniasis

The bottom line

What we know
  • The parasite releases enzymes that cut human antibodies, including the IgA that protects mucosal surfaces.
  • It provokes a heavy influx of neutrophils that causes inflammation without reliably clearing it.
  • Infection produces no lasting protective immunity, and reinfection is common.
  • Partner treatment is part of the treatment, not an optional extra.
What is still open
  • Why the immune response fails to clear it even with a strong inflammatory response.
  • Whether the viruses the parasite carries change how badly people react.

The story, step by step

  1. 1. Cutting antibodies ()
  2. 2. Inflaming, not clearing ()
  3. 3. No memory ()
  4. 4. Passengers ()
  5. 5. What beats it ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

Enzymes that chop your antibodies before they can work

Lab or animal study

What happens

Mucosal surfaces are defended largely by IgA antibodies, which bind pathogens and stop them attaching.

What the research shows

  • T. vaginalis secretes cysteine proteases that cleave human IgA and IgG.
  • A cut antibody cannot flag the parasite for destruction.
  • The same enzymes damage host cells and degrade other defensive proteins.
  • The parasite carries an unusually large number of protease genes.

Why it matters

The immune system's main weapon at this surface is being disassembled as fast as it arrives.

What's still uncertain

  • How much antibody degradation matters relative to other evasion tactics is not settled.

Read more

Next: Inflaming, not clearing

Part 2 of 5

A big immune response that doesn't finish the job

Lab or animal study

What happens

The body responds to the parasite by recruiting neutrophils in large numbers.

What the research shows

  • Neutrophils are the dominant immune cell in trichomoniasis, and they can kill the parasite in a distinctive way, attacking in groups and taking off pieces of it.
  • But the response often fails to eliminate the infection, which can persist for months or years untreated.
  • Meanwhile the inflammation itself damages the lining and contributes to symptoms.
  • Much of the soreness and discharge is this response rather than the parasite directly.

Why it matters

This is a recurring theme across sexually transmitted infections: the damage people feel is often their own immune system working, and failing.

What's still uncertain

  • Why clearance fails despite a vigorous response is unresolved.

Read more

Next: No memory

Part 3 of 5

Why you can get it over and over

Large observational study

What happens

Unlike infections that leave you protected, trichomoniasis leaves little behind.

What the research shows

  • There is no reliable protective immunity after infection, and no vaccine.
  • About 1 in 5 women are infected again within 3 months of treatment.
  • Much of that is reinfection from a partner who was never treated, since most men have no symptoms and are often never tested.
  • Retesting at 3 months is recommended for women for exactly this reason.

Why it matters

Reinfection is not a sign that the treatment failed or that anyone did anything wrong. It is the expected pattern when a partner isn't treated.

What's still uncertain

  • Distinguishing reinfection from treatment failure requires knowing whether the person was re-exposed, which isn't always possible.

Read more

Next: Passengers

Part 4 of 5

The bacterium and the virus it carries

Lab or animal study

What happens

The parasite can host other organisms inside itself, which complicates the immune picture.

What the research shows

  • Mycoplasma hominis, a bacterium, can live inside the parasite.
  • Double-stranded RNA viruses, Trichomonasvirus, infect many strains.
  • Virus-carrying strains have been linked to stronger inflammatory responses and to differences in how the parasite handles metronidazole.
  • One proposal is that treatment releases viral material, which could contribute to symptoms during or just after treatment.

Why it matters

Two people with the same diagnosis may be carrying genuinely different organisms, which may be part of why experiences differ so much.

What's still uncertain

  • This is an active research area, and the idea that treatment-released virus worsens symptoms is a hypothesis rather than an established effect.

Read more

Next: What beats it

Part 5 of 5

What actually works against all this

Randomized trial

What happens

Despite the evasion, the parasite has one clear weakness.

What the research shows

  • Nitroimidazole drugs, metronidazole and tinidazole, are activated inside the parasite's own hydrogenosomes and destroy its DNA.
  • For women, a 7-day course of metronidazole clears the infection more reliably than a single large dose. In a randomized trial, 11% of the 7-day group still had the parasite at the test of cure, against 19% of the single-dose group.
  • Resistance exists and is increasing, and persistent infection may need higher doses or longer courses.
  • Vaginal metronidazole gel does not cure it and is not adequate treatment.

Why it matters

The immune system may not win this one, but a cheap tablet does, provided it's the right course and partners are treated too.

What's still uncertain

  • Resistant infections are difficult to treat and need specialist advice.
  • Alcohol must be avoided during and shortly after treatment with these drugs.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.